Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment

Addictive Behaviors

Volumn 63, Issue , 2016, Pages 132-136

  Davis, Alan K ^a,b   Bonar, Erin E ^c   Ilgen, Mark A ^b,c   Walton, Maureen A ^c   Perron, Brian E ^d   Chermack, Stephen T ^b,c  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cannabis; Marijuana; Substance use problems; Treatment; Veterans

Indexed keywords

MEDICAL CANNABIS; SEDATIVE AGENT;

ADULT; ARTICLE; CHRONIC PAIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POSTTRAUMATIC STRESS DISORDER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RISK FACTOR; SLEEP DISORDER; SUBSTANCE ABUSE; VETERAN; COMPLICATION; DRUG DEPENDENCE; MIDDLE AGED; OUTPATIENT; STATISTICS AND NUMERICAL DATA;

CHRONIC PAIN; FEMALE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; OUTPATIENTS; SLEEP WAKE DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 84979555083     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.07.006     Document Type: Article

References (29)

1. American Psychiatric Association, Diagnostic and statistical manual of mental disorders (4th ed., text rev.). 2000, Author, Washington, DC.
2. Ashrafioun, L., Bohnert, K. M., Jannausch, M., & Ilgen, M., A. (2015). Characteristics of substance use disorder treatment patients using medical cannabis for pain. Addictive Behaviors, 42, 185–188.
3. Bestrashniy, J., Winters, K.C., Variability in medical marijuana laws in the United States. Psychology of Addictive Behaviors 29 (2015), 639–642.
4. Boden, M.T., Babson, K.A., Vujanovic, A.A., Short, N.A., Bonn-Miller, M.O., Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. The American Journal on Addictions 22 (2013), 277–284.
5. Bohnert, K.M., Perron, B.E., Ashrafioun, L., Kleinberg, F., Jannausch, M., Ilgen, M.A., Positive posttraumatic stress disorder screen among first-time medical cannabis patients: Prevalence and association with other substance use. Addictive Behaviors 39 (2014), 1414–1417.
6. Bonn-Miller, M.O., Bucossi, M.M., Trafton, J.A., The underdiagnosis of cannabis use disorders and other axis-I disorders among military veterans within VHA. Military Medicine 177 (2012), 786–788.
7. Bonn-Miller, M.O., Boden, M.T., Bucossi, M.M., Babson, K.A., Self-reported cannabis use characteristics, patters and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse 40 (2014), 23–30.
8. Farrar, J.T., Young, J.P. Jr., LaMoreaux, L., Werth, J.L., Poole, R.M., Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001), 149–158.
9. Gerrity, M.S., Corson, K., Dobscha, S.K., Screening for posttraumatic stress disorder in VA primary care patients with depression symptoms. Journal of General Internal Medicine 22 (2007), 1321–1324, 10.1007/s11606-007-0290-5.
10. Hill, K.P., Medical marijuana for treatment of chronic pain and other medical and psychiatric problems. Journal of the American Medical Association 313 (2015), 2474–2482.
11. Ilgen, M.A., Bohnert, K., Kleinberg, F., Jannausch, M., Bohnert, A.S.B., Walton, M., Blow, F.C., Characteristics of adults seeking medical marijuana certification. Drug and Alcohol Dependence 132 (2013), 654–659.
12. Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine 16 (2001), 606–613 (doi: jgi01114 [pii).
13. Löwe, B., Decker, O., Müller, S., Braähler, E., Schellberg, D., Herzog, W., Herzberg, P.Y., Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care 46 (2008), 266–274.
14. Maii. (2013). Re: Medical marijuana laws around the world [Web blog comment]. [July 9 Retrieved September 25, 2015, from] http://marijuana.cc/2013/07/09/medical-marijuana-laws-around-the-world.
15. Martin, A., Rief, W., Klaiberg, A., Braehler, E., Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General Hospital Psychiatry 28 (2006), 71–77, 10.1016/j.genhosppsych.2005.07.003.
16. National Center for PTSD, The PTSD status form (PSF). 1990, Office of Mental Health Services, Washington, DC.
17. National Center for PTSD, Using the PTSD checklist for DSM-IV (PCL)., 2014 [Retrieved from] http://www.ptsd.va.gov/professional/pages/assessments/assessment-pdf/pcl-handout.pdf.
18. National Conference on State Legislatures, State Medical Marijuana Laws., 2016 [Retrieved May 6, 2016, from] http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx.
19. Okun, M.L., Kravitz, H.M., Sowers, M.F., Moul, D.E., Buysse, D.J., Hall, M., Psychometric evaluation of the insomnia symptom questionnaire: A self-report measure to identify chronic insomnia. Journal of Clinical Sleep Medicine 5 (2009), 41–51.
20. Oliva, E.M., Bowe, T., Harris, A.H.S., Trafton, J.A., False starts in psychotherapy for substance use disorders and PTSD in the VHA. Psychiatric Services, 64, 2013, 722.
21. Oosting, J., Michigan medical marijuana law expanding to include post-traumatic stress disorder., 2014 [Mlive Media Group (March 18, 2014 ed.)] http://www.mlive.com/lansing-news/index.ssf/2014/03/michigan_medical_marijuana_law.html.
22. Osborn, L.A., Lauritsen, K.J., Cross, N., Davis, A.K., Rosenberg, H., Bonadio, F., Lang, B., Self-medication of somatic and psychiatric conditions using botanical marijuana. Journal of Psychoactive Drugs 47 (2015), 345–350.
23. Seal, K.H., Cohen, G., Waldrop, A., Cohen, B.E., Maguen, S., Ren, L., Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: Implications for screening, diagnosis and treatment. Drug and Alcohol Dependence 116 (2011), 93–101.
24. Smith, G.R., Babor, T. Jr., Burnam, M.A., Mosley, C.L., Rost, K., Burns, B., Substance abuse outcomes module User's manual. 1996, University of Arkansas for Medical Sciences, Little Rock, AR.
25. Smith, G.R., Burnam, M.A., Mosley, C.L., Hollenberg, J.A., Mancino, M., Grimes, W., Reliability and validity of the substance abuse outcomes module. Psychiatric Services 57 (2006), 1452–1460.
26. Spitzer, R.L., Kroenke, K., Williams, J.B., Lowe, B., A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine 166 (2006), 1092–1097, 10.1001/archinte.166.10.1092 [166/10/1092 [pii]].
27. Stecker, T., Fortney, J., Owen, R., McGovern, M.P., Williams, S., Co-occurring medical, psychiatric, and alcohol-related disorders among Veterans returning from Iraq and Afghanistan. Psychosomatics 51 (2010), 503–507.
28. Volkow, N.D., Baler, R.D., Compton, W.D., Weiss, S.R.B., Adverse health effects of marijuana use. The New England Journal of Medicine 370 (2014), 2219–2227.
29. Weathers, F.J., Psychometric review of PTSD checklist (PCL-C, PCL-S, PCL-M, PCL-PR). Measurement of stress, trauma, and adaptation, 1996, 250–251.